No insider purchase over the last 90 days. The latest, by Robert Downey, was filed 28 Apr 2026.
Every trade that managers of RR1 disclose to ASX is tracked on this page. The company sits in the Chemicals sector. Between 18 October 2025 and 18 October 2026, 2 insiders published 2 filings.
Every open-market trade in the period is a purchase: 1 purchase worth €1,766, from 1 insider, and not a single sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a purchase of €1,766 by Robert Downey, published on 28 April 2026, equal to 0.015% of the market capitalisation. On the buying side, the filings list 1 senior executive among the declarants.
The latest purchase dates back some time: it was published 173 days ago, on 28 April 2026.
Compared with its exchange (2,530 companies, median 3 filings), a count of 2 filings is below the norm. Over the whole record (from 2026), the tally stands at 1 purchase and no sales.
For comparison within the same sector, see the insider buying recorded at Culp Inc. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended June 2024 · cache
2 of 2 declarations
RR1 is a company operating in the chemicals and materials sector. It is listed on the XASX market.
Purchases our model currently ranks for the recommendations list.
All recommendations